SEQUANA MEDICAL NV (SEQUA.BR) Forecast, Price Target & Analyst Ratings

EBR:SEQUA • BE0974340722

Current stock price

0.487 EUR
-0.01 (-2.6%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SEQUANA MEDICAL NV (SEQUA.BR).

Forecast Snapshot

Consensus Price Target

Price Target
€2.14
+ 339.84% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2025
EPS Estimate
-€0.07
Revenue Estimate
206K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€2.14
Upside
+ 339.84%
From current price of €0.49 to mean target of €2.14, Based on 10 analyst forecasts
Low
€1.52
Median
€2.14
High
€2.84

Price Target Revisions

1 Month
-23.17%
3 Months
-23.17%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for SEQUA.BR. The average price target is 2.14 EUR. This implies a price increase of 339.84% is expected in the next year compared to the current price of 0.487.
The average price target has been revised downward by 23.17% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SEQUA Current Analyst RatingSEQUA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

SEQUA Historical Analyst RatingsSEQUA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.00%
SEQUA.BR was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SEQUA.BR.
In the previous month the buy percentage consensus was at a similar level.
SEQUA.BR was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-01-06KBC SECURITIESMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2025
EPS Estimate
-€0.07
Revenue Estimate
206K
Revenue Q2Q
100.00%
EPS Q2Q
53.33%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
SEQUA.BR revenue by date.SEQUA.BR revenue by date.
922.7K
149.04%		712.2K
-22.81%		105.5K
-85.19%		927K
778.67%		6.541M
605.61%		18.746M
186.59%
EBITDA
YoY % growth
SEQUA.BR ebitda by date.SEQUA.BR ebitda by date.
-27.783M
-25.12%		-28.201M
-1.50%		-17.608M
37.56%		-19.982M
-13.48%		-22.815M
-14.18%		-19.055M
16.48%
EBIT
YoY % growth
SEQUA.BR ebit by date.SEQUA.BR ebit by date.
-28.095M
-24.24%		-28.862M
-2.73%		-18.223M
36.86%		-21.218M
-16.44%		-24.617M
-16.02%		-20.703M
15.90%
Operating Margin
SEQUA.BR operating margin by date.SEQUA.BR operating margin by date.
-3,044.81%-4,052.54%-17,272.99%-2,288.89%-376.35%-110.44%
EPS
YoY % growth
SEQUA.BR eps by date.SEQUA.BR eps by date.
N/A
3.73%		N/A
7.20%		N/A
56.12%		-0.09
81.63%		-0.12
-27.78%		0.01
108.70%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.07
53.33%		-0.07
41.67%
Revenue
Q2Q % growth		206K
100.00%		515K
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		N/AN/A

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SEQUA.BR Yearly Revenue VS EstimatesSEQUA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
SEQUA.BR Yearly EPS VS EstimatesSEQUA.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.42%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
462.98%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-3.53%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SEQUANA MEDICAL NV / SEQUA.BR Forecast FAQ

Can you provide the average price target for SEQUANA MEDICAL NV stock?

10 analysts have analysed SEQUA.BR and the average price target is 2.14 EUR. This implies a price increase of 339.84% is expected in the next year compared to the current price of 0.487.

What are the consensus estimates for SEQUA stock next earnings?

The consensus EPS estimate for the next earnings of SEQUANA MEDICAL NV (SEQUA.BR) is -0.07 EUR and the consensus revenue estimate is 206.00K EUR.

Can you provide the consensus rating for SEQUANA MEDICAL NV stock?

The consensus rating for SEQUANA MEDICAL NV (SEQUA.BR) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.